Afatinib: Moving towards complete, potent and irreversible blockade in EGFR mutation +ve NSCLC
Chairpersons :
P. K. Julka
Speaker :
Dr. Shyam Aggarwal
Afatinib: Moving towards complete, potent and irreversible blockade in EGFR mutation +ve NSCLC
Chairpersons :
P. K. Julka
Speaker :
Dr. Shyam Aggarwal